Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Arthritis and Rheumatism|June 3, 2008
Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosisAlfred D Mahr, Tuhina Neogi, Michael P Lavalley, et al.Lupus Science & Medicine|April 11, 2015
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLEWilliam P Kennedy, Romeo Maciuca, Kristen Wolslegel, et al.Journal of Autoimmunity|March 7, 2015
Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitisLisa C Hinkofer, Amber M Hummel, John H Stone, et al.The Journal of Rheumatology|March 18, 2011
Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosisGunnar Tomasson, Michael Lavalley, Kahraman Tanriverdi, et al.Trials|August 25, 2019
Skeletal muscle hypertrophy and attenuation of cardio-metabolic risk factors (SHARC) using functional electrical stimulation-lower extremity cycling in persons with spinal cord injury: study protocol for a randomized clinical trialAshraf S Gorgey, Refka E Khalil, John C Davis, et al.Annals of Internal Medicine|April 20, 2005
Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) StudyPeter A Merkel, Grace H Lo, Janet T Holbrook, et al.The Journal of Rheumatology|April 21, 2007
Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestationsJodi K Sebastian, Alfred D Mahr, Sohail S Ahmed, et al.Arthritis and Rheumatism|April 13, 2011
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohortFrancisco Silva, Philip Seo, Darrell R Schroeder, et al.The American Journal of Medicine|December 28, 2005
Herpes zoster in immunocompromised patients: incidence, timing, and risk factorsPeter K Wung, Janet T Holbrook, Gary S Hoffman, et al.The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.Pageof 8